Desirudin contraindications

Revision as of 01:30, 3 February 2014 by ShiSheng (talk | contribs) (Created page with "__NOTOC__ {{Desirudin}} {{CMG}}; {{AE}} {{SS}} ==Contraindications== Iprivask is contraindicated in patients with known hypersensitivity to natural or recombinant hirudin...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Desirudin
IPRIVASK® FDA Package Insert
Indications and Usage
Dosage and Administration
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Labels and Packages
Clinical Trials
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]

Contraindications

Iprivask is contraindicated in patients with known hypersensitivity to natural or recombinant hirudins, and in patients with active bleeding and/or irreversible coagulation disorders.[1]


References

  1. ↑ "IPRIVASK (DESIRUDIN) KIT [MARATHON PHARMACEUTICALS, LLC]". Retrieved 3 February 2014.

Template:WikiDoc Sources

Retrieved from "https://www.wikidoc.org/index.php?title=Desirudin_contraindications&oldid=937255"